The Consequences of Innovation Adoption:Is New Drug Adoption Beneficial to Hospitals?

• Main Authors: Fan Chao Shen, 沈凡超
• Other Authors: W. C. Chen
• Format: Others
• Published: 2010
• Online Access: http://ndltd.ncl.edu.tw/handle/38725319641308615441

碩士 === 長庚大學 === 工商管理學系 === 98 === Academically, organizational innovation adoption and its performance impacts has attracted many scholars. But due to the limitation of the data source and research design. Very few research has explored the relationship between the rate of innovation adoption of innovations and organizational growth or performance. The purpose of this thesis attempted to probe Taiwanese hospitals as the sample. In this study, we examine the consequences of innovation adoption by using the context new drug prescribing in medical centers and its association with organizational performance. Many new psychotropic drugs have offered major clinical improvement for patients in the recent year. But it is notable that these brand-name drugs are costly comparing with generic drugs. Therefore, we try to examine whether the adoption of new drugs are beneficial to medical centers in terms of market share and out-patient satisfaction. This study adopts a method of large-sample empirical analysis using Taiwan’s dataset from Bureau of National Health Insurance and Department of Health. It focuses on psychotropic new drug adoption in psychiatric department of Taiwanese medical centers. The empirical results shows that adoption of high novelty (i.e., drugs belong to the category of New Molecular Entity) drugs is positively associated with hospital performance.